High BP medicines may increase vision loss risk


(MENAFN- Khaleej Times) In comparison among those taking a vasodilator medication 19.

certain blood pressure lowering medications may have dangerous side effects as researchers have found a link between taking vasodilators and developing early-stage age-related macular degeneration (amd) that could lead to vision loss and blindness.

amd - the deterioration of the eye’s macula which is responsible for the ability to see fine details clearly - affects millions worldwide.

“as significant as these results may be it is important that they be replicated first and if possible tested in a clinical trials setting before changing anyone’s medication regimens” cautioned ronald klein from university of wisconsin’s school of medicine and public health.

to reach this conclusion the researchers conducted a long-term population-based cohort study from 1988 to 2013 of nearly 5000 people aged 43 to 86 years.

after adjusting for age sex and other factors the researchers found that using any vasodilator such as apresoline and loniten which open (dilate) the blood vessels - was associated with a 72 per cent greater risk of developing early-stage amd.

among people who were not taking vasodilators an estimated 8.2 per cent developed signs of early amd.

in comparison among those taking a vasodilator medication 19.1 per cent developed the disease.

while the study provides risk estimates of associations between blood pressure lowering medications and amd at various stages the researchers cautioned that their study was not able to discern effects of the medications themselves and the conditions for which participants were taking those medications.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.